Nasus Pharma Ltd (NSRX) Operating income 2023–2025
Nasus Pharma Ltd (NSRX) annual operating income history from SEC filings — each fiscal year as reported.
-$4.9MFY2025 · since FY2023: -$1.1M → -$4.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$4.9M | -354.9% |
| FY2024 | -$1.1M | +6.0% |
| FY2023 | -$1.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NSRX financial trends
NSRX RevenueNSRX Net incomeNSRX Net marginNSRX Gross profitNSRX Gross marginNSRX Operating marginNSRX Operating cash flowNSRX Free cash flowNSRX Capital expendituresNSRX Return on equityNSRX Stock buybacksNSRX Dividends paidNSRX Total assetsNSRX Total liabilitiesNSRX Shareholders’ equityNSRX overview →